Associated Papers
Neanderthal and Denisovan Glutamate Dehydrogenase 2 Evolution and Clinical Significance.
Aleshina YA et al.
International Journal of Molecular Sciences, 2025
The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models.
Herencia-Ropero A et al.
Genome Medicine, 2024
39187844 (PubMed )
Supplement: 13073_2024_1370_MOESM3_ESM.xlsx › SNV
Identification of Characteristic Genomic Markers in Human Hepatoma HuH-7 and Huh7.5.1-8 Cell Lines.
Kawamoto M et al.
Frontiers in Genetics, 2020
33193621 (PubMed )
Supplement: Data_Sheet_1.xlsx › Candidate_Gene_Detail
Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset.
Plaitakis A et al.
European Journal of Human Genetics : Ejhg, 2010
The human GLUD2 glutamate dehydrogenase: localization and functional aspects.
Zaganas I et al.
Neurochemistry International, 0
Case report: Whole exome sequencing of circulating cell-free tumor DNA in a follicular thyroid carcinoma patient with lung and bone metastases.
Song J et al.
Journal of Circulating Biomarkers, 0
Select a paper to view details